RxDoctor Payments Data

Lawrence Andrade, MD

Family Medicine · Carthage, MONPI 1619955176

Payments from drug & device makers

$1,058in general payments, 2019–2025

Across 60 payments — averaging $17.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$310
  • Lilly USA, LLC$131
  • Abbott$70
  • Otsuka America Pharmaceutical, Inc.$67
  • Takeda Pharmaceuticals U.S.A., Inc.$59
  • AstraZeneca$52
  • plus $369 from 13 others

What the payments were for

  • Food & beverage$1,058100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,058 in reported general payments places this provider in the 65th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$104,938
Medicare patients
299
Services billed
2,354

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide110$105,422
JanuviaSitagliptin Phosphate54$63,436
EliquisApixaban57$44,479
TrulicityDulaglutide34$43,749
XareltoRivaroxaban51$41,900
JardianceEmpagliflozin33$27,391
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog43$15,270
SymbicortBudesonide/Formoterol Fumarate31$12,620
Lantus SolostarInsulin Glargine,hum.Rec.Anlog78$11,938
MyrbetriqMirabegron15$11,935
FarxigaDapagliflozin Propanediol11$11,709
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$9,251
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$4,796
Losartan Potassium449$4,703
Levothyroxine Sodium383$4,149

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$13$105,422110 claims
MerckJanuvia$43$63,43654 claims
PfizerEliquis$35$44,47957 claims
Lilly USA, LLCTrulicity$131$43,74934 claims
Johnson & JohnsonXarelto$35$41,90051 claims
AstraZenecaSymbicort, Farxiga, Breztri Aerosphere$52$33,58053 claims
Boehringer IngelheimJardiance$14$27,39133 claims
AbbVieSynthroid$37$1,20434 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Carthage

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →